NJ S 944
in committeeExpands epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.
New Jersey · 222 · upper
Quick answers
Did NJ S 944 pass?
Not yet. NJ S 944 is in committee as of 2026-01-13 and has not come to a final vote. Latest recorded action (2026-01-13): Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
What is NJ S 944 about?
NJ S 944 is a bill in the 222 titled “Expands epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.”.
Who sponsors NJ S 944?
Testa, Michael L., Jr., Turner, Shirley K. are the primary sponsors of NJ S 944, joined by 5 cosponsors.
- Introduced
- 2026-01-13
- Latest action
- 2026-01-13 — Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Testa, Michael L., Jr.primary
- Turner, Shirley K.primary
- Burgess, Renee C.cosponsor
- Henry, Owencosponsor
- Gopal, Vincosponsor
- Mukherji, Rajcosponsor
- Amato, Carmen F., Jr.cosponsor
Committees
Not provided by source.
Action timeline
2026-01-13
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-09-12T06:28:14.764501Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=S 944. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.